Summary
- Profile Type
- Business Offer
- POD Reference
- BOHU20240219071
- Term of Validity
- 19 February 2024 - 18 February 2025
- Company's Country
- Hungary
- Type of partnership
- Commercial agreement
- Targeted Countries
- FranceNorwayLuxembourgPolandBelgiumSwedenBulgariaNetherlandsCroatiaFinlandCzechiaSpainIrelandEstoniaDenmarkLithuaniaPortugalLatviaSlovenia
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- The Swiss-Hungarian company is specializing in development and manufacturing food for special medical purposes products for the dietary management of disease-related malnutrition. The products are specially formulated, nutritionally complete, ready-to-drink medical foods. It is looking for companies providing sales representation, distribution, and promotion of clinical nutrition products in several EU countries.
- Full Description
-
It is a Swiss-Hungarian medical nutrition company with in-house research and development capabilities, manufacturing and commercializing its innovative disease/condition-specific, FSMP (Food for Special Medical Purposes) product portfolio.
The company works tirelessly on changing the decades-old, outdated practices in medical nutrition with creating and spreading the new, research-based concept of tailor-made feeding: the condition-specific clinical nutrition.
All of its products are considered as FSMP and they are used to treat patients for malnutrition.
These are specially formulated, nutritionally complete, ready-to-drink medical foods that are processed and intended for the dietary management of diseases, disorders or medical conditions of individuals treated under medical supervision, to contribute to the efficacy of the medical treatment, help patients to fight the disease and recover more quickly.
All products can be reimbursed and available through prescription by doctors (Rx, OTC) via classic pharma channel sales in EU countries and depending on the market, the products can be also distributed via public and private hospitals, care homes or to all kind of medical and allied healthcare practitioners as well. The company also has standard products for hospital tenders.
The company’s main objective is to build its global presence via distribution partners, who would also benefit from having this well-recognized brand in their portfolio.
The SME would like to become a long-term strategic partner for distributors who believe in its uniqueness originating from its science-based approach and are eager to bring its innovative approach to the field of clinical nutrition in their territory. - Advantages and Innovations
-
The offered products are specially formulated, nutritionally complete, ready-to-drink medical foods that have been developed based on results of the latest scientific research and have the following added-values:
• condition-specific formulation according to specific nutritional needs of different pathologies (cancer, COPD, IBD, CF, etc.)
• high energy density (2-2,2 kcal/ml) mainly from protein and fat
• contains all vitamins, minerals, and trace elements, suitable as soler-source nutrition
• rich in omega-3 fatty acid content
• available in several delicious flavours
• suitable for diabetic patients because of the low carbohydrate content
• high compliance level with consumption needs
• high-quality FSMP with a very good quality/price ratio
Main areas of application
- Oncology, for cancer patients
- Pulmonology, for Chronic obstructive pulmonary disease and cystic fibrosis
- Gastroenterology, for Inflammatory Bowel Disease (IBD), Crohn’s disease
- Elderly, for malnutrition in older adults
- Surgery, for the preoperative dietary management of surgery patients - Stage of Development
- Already on the market
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR description
-
The company can be a partner of choice to distributors who already have knowledge of the local clinical nutrition market and/or are present with existing portfolio in therapeutic areas such as oncology, respiratory or gastroenterology (and/or other areas where disease-related malnutrition occurs) – as the products are excellent complementary in these conditions.
To successfully launch its product portfolio on a new market it is an advantage if its future partner already has experience in drug promotion in therapeutic areas mentioned above and can provide a dedicated team (medical and/or regulatory expert, marketing, and sales personnel) to handle registration process and promotion activities from the beginning of the partnership.
Partner Sought
- Expected Role of a Partner
-
Type of partner sought:
• importer, distributor of pharmaceutical and/or food supplement product
Specific area of activity of the partner:
• Drug and/or food supplement registration, sales representation, and medical promotion
Task to be performed:
• Responsible for required local notification/registration process
• Providing market launch strategy with at least 1-year business plan
• Executing promotion and marketing activities
• Providing a dedicated team to the product promotion: Medical/regulatory expert, sales, and marketing person) - Type and Size of Partner
- SME 50 - 249SME 11-49
- Type of partnership
- Commercial agreement
Call details
- Coordinator required
-
Yes
Dissemination
- Market keywords
- 05005009 - Paediatrics05005007 - Pulmonary medicine05005014 - Oncology05005004 - Gastroenterology07003002 - Health food
- Sector Groups Involved
- Health
- Targeted countries
- FranceNorwayLuxembourgPolandBelgiumSwedenBulgariaNetherlandsCroatiaFinlandCzechiaSpainIrelandEstoniaDenmarkLithuaniaPortugalLatviaSlovenia